SCO-301

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSCO-301
Drug Alias Namerepurposed drug (Scandion Oncology)SCO-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLung NeoplasmsOvarian Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesScandion Oncology As
China Registration ClassN/A

Develop Information

Active CompaniesScandion Oncology As
Inactive CompaniesN/A
Active IndicationsSolid tumoursLung NeoplasmsOvarian Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A